Summary

Kemisk blokeret antistof Microarray for Multiplexed Højkapacitetsforskning Profilering af specifikke protein Glycosylering i komplekse prøver

Published: May 04, 2012
doi:

Summary

I denne undersøgelse beskriver vi en forbedret protokol til et multiplekset high-throughput-antistof mikroarray med lectin påvisningsmetode, der kan anvendes i glycosylering profilering af specifikke proteiner. Denne protokol indeholder nye pålidelige reagenser og reducerer den tid, omkostninger og lab krav til udstyr i forhold til den tidligere procedure.

Abstract

In this study, we describe an effective protocol for use in a multiplexed high-throughput antibody microarray with glycan binding protein detection that allows for the glycosylation profiling of specific proteins. Glycosylation of proteins is the most prevalent post-translational modification found on proteins, and leads diversified modifications of the physical, chemical, and biological properties of proteins. Because the glycosylation machinery is particularly susceptible to disease progression and malignant transformation, aberrant glycosylation has been recognized as early detection biomarkers for cancer and other diseases. However, current methods to study protein glycosylation typically are too complicated or expensive for use in most normal laboratory or clinical settings and a more practical method to study protein glycosylation is needed. The new protocol described in this study makes use of a chemically blocked antibody microarray with glycan-binding protein (GBP) detection and significantly reduces the time, cost, and lab equipment requirements needed to study protein glycosylation. In this method, multiple immobilized glycoprotein-specific antibodies are printed directly onto the microarray slides and the N-glycans on the antibodies are blocked. The blocked, immobilized glycoprotein-specific antibodies are able to capture and isolate glycoproteins from a complex sample that is applied directly onto the microarray slides. Glycan detection then can be performed by the application of biotinylated lectins and other GBPs to the microarray slide, while binding levels can be determined using Dylight 549-Streptavidin. Through the use of an antibody panel and probing with multiple biotinylated lectins, this method allows for an effective glycosylation profile of the different proteins found in a given human or animal sample to be developed.

Introduction

Glycosylation of protein, which is the most ubiquitous post-translational modification on proteins, modifies the physical, chemical, and biological properties of a protein, and plays a fundamental role in various biological processes1-6. Because the glycosylation machinery is particularly susceptible to disease progression and malignant transformation, aberrant glycosylation has been recognized as early detection biomarkers for cancer and other diseases 7-12. In fact, most current cancer biomarkers, such as the L3 fraction of α-1 fetoprotein (AFP) for hepatocellular carcinoma 13-15, and CA199 for pancreatic cancer 16, 17 are all aberrant glycan moieties on glycoproteins. However, methods to study protein glycosylation have been complicated, and not suitable for routine laboratory and clinical settings. Chen et al. has recently invented a chemically blocked antibody microarray with a glycan-binding protein (GBP) detection method for high-throughput and multiplexed profile glycosylation of native glycoproteins in a complex sample 18. In this affinity based microarray method, multiple immobilized glycoprotein-specific antibodies capture and isolate glycoproteins from the complex mixture directly on the microarray slide, and the glycans on each individual captured protein are measured by GBPs. Because all normal antibodies contain N-glycans which could be recognized by most GBPs, the critical step of this method is to chemically block the glycans on the antibodies from binding to GBP. In the procedure, the cis-diol groups of the glycans on the antibodies were first oxidized to aldehyde groups by using NaIO4 in sodium acetate buffer avoiding light. The aldehyde groups were then conjugated to the hydrazide group of a cross-linker, 4-(4-N-MaleimidoPhenyl)butyric acid Hydrazide HCl (MPBH), followed by the conjugation of a dipeptide, Cys-Gly, to the maleimide group of the MPBH. Thus, the cis-diol groups on glycans of antibodies were converted into bulky none hydroxyl groups, which hindered the lectins and other GBPs bindings to the capture antibodies. This blocking procedure makes the GBPs and lectins bind only to the glycans of captured proteins. After this chemically blocking, serum samples were incubated with the antibody microarray, followed by the glycans detection by using different biotinylated lectins and GBPs, and visualized with Cy3-streptavidin. The parallel use of an antibody panel and multiple lectin probing provides discrete glycosylation profiles of multiple proteins in a given sample 18-20. This method has been used successfully in multiple different labs 1, 7, 13, 19-31. However, stability of MPBH and Cys-Gly, complicated and extended procedure in this method affect the reproducibility, effectiveness and efficiency of the method. In this new protocol, we replaced both MPBH and Cys-Gly with one much more stable reagent glutamic acid hydrazide (Glu-hydrazide), which significantly improved the reproducibility of the method, simplified and shorten the whole procedure so that the it can be completed within one working day. In this new protocol, we describe the detailed procedure of the protocol which can be readily adopted by normal labs for routine protein glycosylation study and techniques which are necessary to obtain reproducible and repeatable results.

Protocol

1. Udskrive en Antistof Microarray for assayet Fortyndes alle antistoffer til 0,5 mg / ml i phosphatbufret saltvand, pH 7,2 (PBS). Portion 40 ul af hvert antistof i 384-brønds kilde plade. Læg 384-brønds source plade på Scienion sciFLEXARRAYER microarrayer. Læg 20 PATH microarray glider på microarrayer som mål. Indstille microarrayer at udskrive 48 identiske subarrays, hvor 27-antistoffer og kontrol proteiner plettede in triplo i en 9×9 mønster (fig. 1E,…

Discussion

1. Target protein og capture Antibody Selection

Forud for antistoffet mikroarray assayet nogle reagenser og materialer for at blive betragtet og fremstilles. At designe et antistof microarray for glycan profilering eller glycan biomarkør screening, et panel af antistoffer specifikke for glycoprotein ansøgere skal fastlægges i henhold til litteraturen eller fra tidligere resultater. Disse antistoffer var normalt købt fra forskellige leverandører, såsom R & D Systems mv IgG foretrækkes…

Divulgazioni

The authors have nothing to disclose.

Acknowledgements

Dette arbejde blev støttet af Institut for hepatitis og Virus Research.

Materials

ID Name of the reagent Abbreviation Company Catalog #
L1 Biotinylated Concanavalin A ConA Vector Laboratories BK-1000
L2 Biotinylated Sambucus Nigra Lectin SNA Vector Laboratories B-1305
L3 Biotinylated Lens Culinaris Agglutinin LCA Vector Laboratories BK-2000
L4 Biotinylated Ricinus Communis Agglutinin I RCA Vector Laboratories BK-1000
L5 Biotinylated Aleuria Aurantia Lectin AAL Vector Laboratories B-1395
L6 Biotinylated Erythrina Cristagalli Lectin ECL Vector Laboratories BK-3000
L7 Biotinylated Griffonia (Bandeiraea) Simplicifolia Lectin II GSL II Vector Laboratories BK-3000
L8 Biotinylated Wheat Germ Agglutinin WGA Vector Laboratories BK-1000
L9 Biotinylated Phaseolus vulgaris Erythroagglutinin PHA-E Vector Laboratories BK-2000
L10 Biotinylated Phaseolus vulgaris Leucoagglutinin PHA-L Vector Laboratories BK-2000
L11 Biotinylated Peanut Agglutinin PNA Vector Laboratories BK-1000
L12 Biotinylated Pisum Sativum Agglutinin PSA Vector Laboratories BK-2000
L13 Biotinylated Dolichos Biflorus Agglutinin DBA Vector Laboratories BK-1000
L14 Biotinylated Datura Stramonium Lectin DSL Vector Laboratories BK-3000
L15 Biotinylated Sophora Japonica Agglutinin SJA Vector Laboratories BK-2000
L16 Biotinylated Soybean Agglutinin SBA Vector Laboratories BK-1000
L17 Biotinylated Solanum Tuberosum (Potato) Lectin STL Vector Laboratories BK-3000
L18 Biotinylated Griffonia (Bandeiraea) Simplicifolia Lectin I GSL I Vector Laboratories BK-2000
L19 Biotinylated Vicia Villosa Lectin VVL Vector Laboratories BK-2000
L20 Biotinylated Lycopersicon Esculentum (Tomato) Lectin LEL Vector Laboratories BK-3000
L21 Biotinylated Ulex Europaeus Agglutinin I UEA I Vector Laboratories BK-1000
L22 Biotinylated Jacalin JACALIN Vector Laboratories BK-3000
A1 Goat F(ab’)2 Fragment anti-human IgM, Fc5μ antibody IgM Jackson Immuno Research 109-006-129
A2 Donkey F(ab’)2 Frag anti-human IgG (H+L) antibody AB1 Jackson Immuno Research 709-006-149
A3 Mouse anti-human IgG F(ab’)2 monoclonal antibody AB3 Jackson Immuno Research 209-005-097
A4 Goat anti-human alpha 2 macroglobulin polyclonal antibody A2M GeneTex GTX62924
A5 Rabbit anti-human alpha-1-antitrypsin polyclonal antibody A1AT Lee Biosiences CA1T-80A
A6 Mouse anti-human alpha-1-antitrypsin monoclonal antibody A1AT Sigma Aldrich SAB4200198
A7 Rabbit anti-human alpha-1-antitrypsin polyclonal antibody ACT NeoMarkers RB-367-A1
A8 Rabbit anti-human alpha-1-antichymotrypsin polyclonal antibody ACT Fisher Scientific RB9213R7
A9 Mouse anti-human transferrin monoclonal antibody Transferrin GeneTex GTX101035
A10 Rabbit anti-human transferrin polyclonal antibody Transferrin GeneTex GTX77130
A11 Goat anti-human apolipoprotein J polyclonal antibody ApoJ Abcam ab7610
A12 Mouse anti-human GP73 monoclonal antibody GP73 Abbott 14H4-23
A13 Mouse anti-human GP73 monoclonal antibody GP73 SANTA CRUZ BIOTECHNOLOGY INC sc-101275
A14 Rabbit anti-human alpha-1 fetoprotein polyclonal antibody AFP GenWay GWB-41C966
A15 Mouse anti-human alpha-1 fetoprotein monoclonal antibody AFP Fitzgerald 10-A05A
A16 Mouse anti-human hemopexin monoclonal antibody Hemopexin Assaypro 60190-05011
A17 Mouse anti-human glypican-3(1G12) monoclonal antibody GPL3 Santa Cruz Bio sc-65443
A18 Mouse anti-human Kininogen (LMW) monoclonal antibody Kininogen Assaypro 20333-05011
A19 Rabbit anti-human MMP-21 monoclonal antibody MMP21 Epitomic 1955-1
A20 Mouse anti-human CEACAM-1 monoclonal antibody CEACAM R&D Systems MAB1180
A21 Rat anti-human DPPIV/CD26 monoclonal antibody DPPIV R&D Systems MAB22441
A22 Mouse anti-human PIVKA II monoclonal antibody PIVICA Crystal chem 8040
A23 Mouse anti-carcinoembryonic antigen CEA US biological C1300
A24 Mouse anti-CA125 Cancer Antigen CA125 US biological C0050-01D
A25 Mouse anti -CA19-9 Cancer antigen CA19-9 US biological C0075-18
A26 Mouse anti-Lewis x monoclonal antibody Lewis X Calbiochem 434631
bio Biotinylated BSA (positive control) Bio Home-made N/A

Table 1. List of lectins and antibodies used in this protocol.

Name of the reagent s/equipments Company Catalogue number
Non contact microarrayer BioDot Inc sciFLEXARRAYER
384 microplate Fisher 14-230-243
FoodSaver FoodSaver V3835
Ultrathin nitrocellulose coate microarray slides Gentel PATH
Slide Imprinter (optional) The Gel Company WSP60-1
Shaker Fisher 15-453-211
Centrifuge Eppendorf 5804 000.013
Slide washing basin/Slide Staining Dish with Removable Rack Fisher 08-812
Slide incubation chamber/microscope slide box Fisher 03-448-5
Brij 35, 30 w/v% solution in water Acros Organics AC32958-0025
Tween-20 Fisher P337-100
Sodium Periodate (NaIO4) Sigma 311448
L-Glutamic acid γ-hydrazide Sigma G-7257
Sodium Acetate Anhydrous (CH3COONa) Sigma S2889
Bovine Serum Albumin (BSA) Lampire Biological Labs 7500804
Phosphate Buffer Saline (PBS) (10X) Denville Scientific CP4390-48
Dylight 549 conjugated NeutrAvidin Thermo 22837
Protease Inhibitor Cocktail Tablets Roche 4693159001
ChromPure Human IgG, Fc fragment Jackson Immunoresearch 009-000-008
ChromPure Human IgG, whole molecule Jackson Immunoresearch 009-000-003
ChromPure Mouse IgG, whole molecule Jackson Immunoresearch 015-000-003
ChromPure Mouse IgG, Fc fragment Jackson Immunoresearch 015-000-008
ChromPure Rabbit IgG, whole molecule Jackson Immunoresearch 011-000-003
ChromPure Donkey IgG, whole molecule Jackson Immunoresearch 017-000-003
Microarray Scanner Tecan LS Reloaded

Table 2. List of equipments and reagents used in this protocol.

Riferimenti

  1. Fang, M. The ER UDPase ENTPD5 promotes protein N-glycosylation, the Warburg effect, and proliferation in the PTEN pathway. Cell. 143, 711-724 (2010).
  2. Marino, K., Bones, J., Kattla, J. J., Rudd, P. M. A systematic approach to protein glycosylation analysis: a path through the maze. Nat. Chem. Biol. 6, 713-723 (2010).
  3. Shental-Bechor, D., Levy, Y. Effect of glycosylation on protein folding: a close look at thermodynamic stabilization. Proc. Natl. Acad. Sci. U. S. A. 105, 8256-8261 (2008).
  4. Hossler, P., Khattak, S. F., Li, Z. J. Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology. 19, 936-949 (2009).
  5. Nothaft, H., Szymanski, C. M. Protein glycosylation in bacteria: sweeter than ever. Nat. Rev. Microbiol. 8, 765-778 (2011).
  6. Sola, R. J., Griebenow, K. Effects of glycosylation on the stability of protein pharmaceuticals. J. Pharm. Sci. 98, 1223-1245 (2009).
  7. Li, C., Lubman, D. M. Analysis of serum protein glycosylation with antibody-lectin microarray for high-throughput biomarker screening. Methods Mol. Biol. 723, 15-28 (2011).
  8. Dwek, M. V., Jenks, A., Leathem, A. J. A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia. Clin. Chim. Acta. 411, 1935-1939 (2010).
  9. Drake, P. M. Sweetening the pot: adding glycosylation to the biomarker discovery equation. Clin. Chem. 56, 223-236 (2010).
  10. Kim, Y. -. P., Park, S., Oh, E., Oh, Y. -. H., Kim, H. -. S. On-chip detection of protein glycosylation based on energy transfer between nanoparticles. Biosensors & Bioelectronics. 24, 1189-1194 (2009).
  11. Boland, M., Rudd, P. M. Disease related glycosylation changes and biomarker discovery: challenges and possibilities in an emerging field. Editorial. Dis. Markers. 25, 189-192 (2008).
  12. Norton, P. A. N-linked glycosylation of the liver cancer biomarker GP73. J. Cell Biochem. 104, 136-149 (2008).
  13. Nakagawa, T. Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients. J. Proteome Res. 7, 2222-2233 (2008).
  14. Durazo, F. A. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. J. Gastroenterol Hepatol. 23, 1541-1548 (2008).
  15. Kobayashi, M. Fucosylated fraction of alpha-fetoprotein, L3, as a useful prognostic factor in patients with hepatocellular carcinoma with special reference to low concentrations of serum alpha-fetoprotein. Hepatol. Res. 37, 914-922 (2007).
  16. Maisey, N. R. CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials. Br. J. Cancer. 93, 740-743 (2005).
  17. Talar-Wojnarowska, R. Clinical value of serum neopterin, tissue polypeptide-specific antigen and CA19-9 levels in differential diagnosis between pancreatic cancer and chronic pancreatitis. Pancreatology. 10, 689-694 (2010).
  18. Chen, S. Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays. Nat. Methods. 4, 437-444 (2007).
  19. Shao, C. Antibody microarray analysis of serum glycans in esophageal spuamous cell carcinoma cases and controls. Proteomics Clinical Applications. 3, 923-931 (2009).
  20. Chen, S., Haab, B. B. Analysis of glycans on serum proteins using antibody microarrays. Methods Mol. Biol. 520, 39-58 (2009).
  21. Yue, T. The Prevalence and Nature of Glycan Alterations on Specific Proteins in Pancreatic Cancer Patients Revealed Using Antibody-Lectin Sandwich Arrays. Molecular & Cellular Proteomics. 8, 1697-1707 (2009).
  22. Wolf-Yadlin, A., Sevecka, M., MacBeath, G. Dissecting protein function and signaling using protein microarrays. Current Opinion in Chemical Biology. 13, 398-405 (2009).
  23. Richard, E. Proteomics as Applied to Inherited Metabolic Diseases. Current Proteomics. 6, 140-153 (2009).
  24. Nolen, B., Winans, M., Marrangoni, A., Lokshin, A. Aberrant tumor-associated antigen autoantibody profiles in healthy controls detected by multiplex bead-based immunoassay. Journal of Immunological Methods. 344, 116-120 (2009).
  25. Kuno, A. Focused Differential Glycan Analysis with the Platform Antibody-assisted Lectin Profiling for Glycan-related Biomarker Verification. Molecular & Cellular Proteomics. 8, 99-108 (2009).
  26. Hsu, K. -. L., Mahal, L. K. Sweet tasting chips: microarray-based analysis of glycans. Current Opinion in Chemical Biology. 13, 427-432 (2009).
  27. Borrebaeck, C. A. K., Wingren, C. High-throughput proteomics using antibody microarrays: an update. Expert Review of Molecular Diagnostics. 7, 673-686 (2007).
  28. Sanchez-Carbayo, M. Antibody array-based technologies for cancer protein profiling and functional proteomic analyses using serum and tissue specimens. Tumor Biology. 31, 103-112 (2010).
  29. Porter, A. A motif-based analysis of glycan array data to determine the specificities of glycan-binding proteins. Glycobiology. 20, 369-380 (2010).
  30. Maupin, K. A. Glycogene Expression Alterations Associated with Pancreatic Cancer Epithelial-Mesenchymal Transition in Complementary Model Systems. Plos One. 5, (2010).
  31. Sevecka, M., Wolf-Yadlin, A., MacBeath, G. Lysate Microarrays Enable High-throughput, Quantitative Investigations of Cellular Signaling. Molecular & Cellular Proteomics. 10, (2011).
  32. Wang, M. Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma. Cancer Epidemiol. Biomarkers Prev. 18, 1914-1921 (2009).
check_url/it/3791?article_type=t

Play Video

Citazione di questo articolo
Lu, C., Wonsidler, J. L., Li, J., Du, Y., Block, T., Haab, B., Chen, S. Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples. J. Vis. Exp. (63), e3791, doi:10.3791/3791 (2012).

View Video